Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
COMMD5 pseudogene 1 (COMMD5P1) is a non-coding genetic element classified as a pseudogene of the COMMD5 gene, which belongs to the COMM domain-containing protein family. Unlike its parent gene COMMD5, which is involved in epithelial cell phenotype regulation and has both tumor suppressor and oncogenic roles in some human cancers[2][3], COMMD5P1 is not transcribed into a functional protein and does not participate directly in known biological pathways or disease mechanisms. As a pseudogene, COMMD5P1 is not considered a therapeutic target, biomarker, or druggable receptor/enzyme, nor does it provide structure or function relevant to pharmacological intervention. No drugs, therapeutic mechanisms, or disease roles have been described for COMMD5P1; information on cellular function, disease relevance, and molecular interaction pertains to functional *COMMD5* or other COMMD family members, not the pseudogene[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on COMMD5 pseudogene 1 (COMMD5P1).